Mercator Medical (FRA:MM2) Tax Expense: €1.6 Mil (TTM As of Mar. 2026)


FRA:MM2 Mercator Medical SA FRA:MM2
63 GF Score
Price €11.20
GF Value €11.71
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Mercator Medical Tax Expense?

Mercator Medical FRA:MM2 +0.18% 63 Tax Expense is €1.6 Mil as of Mar. 2026. GuruFocus rates FRA:MM2 with a GF Score™ of 63/100 and a GF Value™ of €11.71 (Fairly Valued). The stock has 2 warning signs investors should review.

Mercator Medical's tax expense for the months ended in Mar. 2026 was €-0.5 Mil. Its tax expense for the trailing twelve months (TTM) ended in Mar. 2026 was €1.6 Mil.


Mercator Medical  (FRA:MM2) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Mercator Medical Tax Expense Related Terms


Mercator Medical Tax Expense Historical Data

* Premium members only.

The historical data trend for Mercator Medical's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mercator Medical Tax Expense Chart

Mercator Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Tax Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.54 1.07 4.44 -1.86 -0.22

Mercator Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.35 0.74 0.26 1.14 -0.51
FRA:MM2
63GF Score
Mercator Medical SA FRA:MM2
Tax Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mercator Medical Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Expense →
What does a Tax Expense of €1.6 Mil mean?
Mercator Medical (FRA:MM2) has a Tax Expense of €1.6 Mil as of Mar. 2026. Tax expense is the amount of tax the company pays in an accounting period. View historical data on Mercator Medical and its competitors.
Is Mercator Medical's Tax Expense too high?
Mercator Medical's current Tax Expense is €1.6 Mil. Overall, Mercator Medical has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Mercator Medical's Tax Expense compare to ISRG and BDX?
Mercator Medical's Tax Expense of €1.6 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Expense for a Medical Devices & Instruments company?
A good Tax Expense depends on the Medical Devices & Instruments industry context. However, Tax Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Expense mean?
A high Tax Expense can signal that a stock is expensive relative to its fundamentals. Tax expense is the amount of tax the company pays in an accounting period. View historical data on Mercator Medical and its competitors. Mercator Medical's current Tax Expense is €1.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mercator Medical stock overvalued right now?
Based on GuruFocus' analysis, Mercator Medical (FRA:MM2) is currently considered Fairly Valued. The stock's GF Value™ is €11.71, compared to a current price of €11.20 — trading 4.4% below its estimated fair value. The current Tax Expense is €1.6 Mil. Mercator Medical's overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Expense calculated?
Tax Expense is calculated from a company's financial statements. For Mercator Medical (FRA:MM2), the current Tax Expense is €1.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mercator Medical (FRA:MM2) Overvalued in 2026?

Based on GuruFocus' analysis, Mercator Medical stock appears to be undervalued. The current stock price of €11.20 is trading 4.4% below its estimated GF Value™ of €11.71. GuruFocus considers Mercator Medical to be Fairly Valued.

Key valuation signals for FRA:MM2:

  • Tax Expense: €1.6 Mil
  • GF Value™: €11.71 vs. price of €11.20 (4.4% below fair value)
  • GF Score™: 63/100 with 2 warning signs

No single metric tells the full story. See the FRA:MM2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Mercator Medical Business Description

Other Exchanges MRC:Poland
Address Ulica H. Modrzejewska 30, Krakow, POL, 31-327
Mercator Medical SA produces and sells medical gloves and distributor of medical disposables. The company's products - mainly gloves, dressings, disposable clothing and surgical drapes. It operates in Europe and Russia.
63GF Score

Get the complete analysis for FRA:MM2

Tax Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.20
Price
€11.71
GF Value